In the healthcare and pharmaceutical industry, the quality and purity of raw materials like Titanium Dioxide (TiO₂) is critical. Whether used for UV protection in topical formulations or as a coating for tablets, TiO₂ must meet stringent regulatory requirements.
At RSSL, we specialise in full monograph testing of Titanium Dioxide, ensuring compliance with the United States Pharmacopoeia (USP), European Pharmacopoeia (Ph. Eur.) and Japanese Pharmacopoeia (JP).
Our expert team utilises advanced wet chemistry techniques, delivering precise and reliable results.
Titanium Dioxide (TiO₂) is a key pharmaceutical excipient that demands rigorous purity testing.
Each of the regional pharmacopeial standard has different requirements and methodologies. RSSL’s expertise in titrations, gravimetric analysis and complex wet chemistry techniques along with state-of-the-art facilities enables the handling of challenging assays with high precision whilst still ensuring materials meet USP, Ph. Eur. and JP regulatory standards.
The USP assay employs the Jones reductor method to precisely determine TiO₂ content
The EP assay follows a controlled redox titration approach:
The JP assay employs a gravimetric approach to assess TiO₂ purity, this method provides a highly accurate, weight-based purity assessment of TiO₂.
1. Conversion – TiO₂ is rendered soluble via potassium pyrosulfate fusion in platinum crucibles.
2. Purification – Includes hydrogen sulfide treatments and final precipitation with Cupferron.
3. Quantification – Purity is determined through ignition in a muffle furnace.
Our rigorous wet chemistry techniques ensure your Titanium Dioxide data meets the highest pharmaceutical standards—guaranteeing safety, compliance and performance.